Rossari Biotech Ltd (NSE:ROSSARI)

Q4 2026 Rossari Biotech Ltd Earnings Call Transcript

Apr 28, 2026 / 11:30 AM GMT

Release Date Price: ₹468.95 (-6.99%)

Transcript

Key Points

Positve

Rossari Biotech Ltd (BOM:543213) achieved its highest ever quarterly revenue and EBITDA performance in Q4 FY26.
The company reported a 15% year-on-year revenue growth for FY26, driven primarily by volume increases.
All three business segments delivered healthy double-digit growth, with HVPC growing by 20%, textiles by 10%, and AHN by 11%.
The company is focusing on R&D and innovation, setting up a new R&D facility in Navi Mumbai to enhance product development and application-led research.
Rossari Biotech Ltd (BOM:543213) is expanding its international footprint, with exports growing by 11% year-on-year, supported by deeper engagement with existing customers and expansion into new geographies.

Negative

EBITDA margins decreased from 12.7% in FY25 to 11.9% in FY26, influenced by the prevailing cost environment.
The company faced challenges in the institutional and B2C businesses, which operated in a challenging environment, impacting overall profitability.
Raw material price increases, some as high as 25-30%, affected costs, although some of these increases have been passed on to customers.
The ongoing geopolitical developments in the Middle East have created uncertainty across vulnerable markets, supply chains, and logistics.
The company has postponed some of its planned CapEx due to evolving business requirements and market conditions, impacting future growth potential.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ROSB.NS - Rossari Biotech Ltd
Q4 2026 Rossari Biotech Ltd Earnings Call
Apr 28, 2026 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, Good day and welcome to Razari Biotech Limited's Earnings Conference Call.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing start and read on a touchtone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Mitesh Jain from CDR India.

Thank you, and over to you, Mr. Jain.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.